FdaApplication
NDA 022401
Identifiers
- fda_app_no: NDA022401
Properties
| Property | Value |
|---|---|
| applicant_name | BOEHRINGER INGELHEIM PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2009-10-16 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TWYNSTA | AMLODIPINE BESYLATE; TELMISARTAN | EQ 10MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| TWYNSTA | AMLODIPINE BESYLATE; TELMISARTAN | EQ 5MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| TWYNSTA | AMLODIPINE BESYLATE; TELMISARTAN | EQ 5MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| TWYNSTA | AMLODIPINE BESYLATE; TELMISARTAN | EQ 10MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
4 products